Acquired Orphan Blood Diseases Therapeutics Market Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential to 2019


“The Report Acquired Orphan Blood Diseases Therapeutics Market to 2019 – Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

Summary

GBI Research has released its latest research, Acquired Orphan Blood Diseases Therapeutics Market to 2019 Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential. The report provides insights into the up-and-coming trends of a portion of the acquired orphan blood disorder pharmaceutical market by examining Idiopathic Thrombocytopenic Purpura (ITP), Myelodysplastic Syndrome (MDS), Myelofibrosis (MF), Paroxysmal Nocturnal Hemoglobinuria (PNH) and Polycythemia Vera (PV) in seven major markets: the US, the top five European countries (France, Germany, Italy, Spain and the UK) and Japan.

The report includes market forecasts to 2019, detailed pipeline analysis, in-depth profiling of major products and details of recent industry deals.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.

The MF market will be the fastest growing of the five markets during the forecast period, at a Compound Annual Growth Rate (CAGR) of 34% and reaching a total market size of $1.1bn in 2019. MDS represents the largest market, expected to reach $2.2bn by 2019.

View Report At :http://www.marketresearchreports.biz/analysis/163920

Scope

  • urrent and future treatment trends for three rare diseases

  • Market forecasts for five rare diseases across seven major markets

  • Analysis of the developmental pipelines for five rare diseases

  • Information on recent industry deals

Reasons to buy

  • Understand how the inherited orphan blood diseases market has developed and is continuing to develop within the featured markets

  • Predict which products are likely to be most successful in the future

  • Gain an understanding of the possible market available for specific products

Download Sample copy of this Report at : http://www.marketresearchreports.biz/sample/sample/163920

Table of Contents

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 6

1.2 List of Figures 7

2 Acquired Orphan Blood Diseases – Introduction 9

2.1 Overview 9

3 Acquired Orphan Blood Diseases – Therapeutic Landscape 10

3.1 Paroxysmal Nocturnal Hemoglobinuria 10

3.1.1 Disease Overview 10

3.1.2 Revenues 12

3.1.3 Revenue Analysis by Country 13

3.1.4 Annual Cost of Therapy 17

3.1.5 Treatment Usage Patterns 18

3.1.6 Marketed Products 19

3.1.7 Market Drivers 20

3.1.8 Market Restraints 20

3.2 Paroxysmal Nocturnal Hemoglobinuria: Research and Development Pipeline 21

3.2.1 Overview 21

3.2.2 Trends in Paroxysmal Nocturnal Hemoglobinuria Pipeline 23

3.2.3 Promising Pipeline Molecules 24

3.2.4 Key Takeaway 24

3.3 Idiopathic Thrombocytopenic Purpura 25

3.3.1 Disease Overview 25

3.3.2 Revenues 27

3.3.3 Revenue Analysis by Country 28

3.3.4 Annual Cost of Therapy 32

3.3.5 Treatment Usage Patterns 33

3.3.6 Marketed Products 34

3.3.7 Market Drivers 34

3.3.8 Market Restraints 34

3.4 Idiopathic Thrombocytopenic Purpura: Research and Development Pipeline 35

3.4.1 Overview 35

3.4.2 Pipeline by Clinical Phase of Development 36

3.4.3 Trends in Idiopathic Thrombocytopenic Purpura Pipeline 40

3.4.4 Promising Pipeline Molecules 41

3.4.5 Key Takeaway 43

3.5 Myelodysplastic Syndrome 44

3.5.1 Disease Overview 44

3.5.2 Revenues 45

3.5.3 Revenue Analysis by Country 46

3.5.4 Annual Cost of Therapy 50

3.5.5 Treatment Usage Patterns 51

3.5.6 Marketed Products 52

3.5.7 Market Drivers 53

3.5.8 Market Restraints 53

3.6 Myelodysplastic Syndrome: Research and Development Pipeline 54

3.6.1 Overview 54

3.6.2 Pipeline by Clinical Phase of Development 55

3.6.3 Trends in Myelodysplastic Syndrome Pipeline 80

3.6.4 Promising Pipeline Molecules 83

3.6.5 Key Takeaway 83

3.7 Myelofibrosis 84

3.7.1 Disease Overview 84

3.7.2 Revenues 85

3.7.3 Revenue Analysis by Country 86

3.7.4 Annual Cost of Therapy 90

3.7.5 Treatment Usage Patterns 91

3.7.6 Marketed Products 92

3.7.7 Market Drivers 92

3.7.8 Market Restraints 92

3.8 Myelofibrosis: Research and Development Pipeline 93

3.8.1 Overview 93

3.8.2 Pipeline by Clinical Phase of Development 94

3.8.3 Trends in Myelofibrosis Pipeline 99

3.8.4 Promising Pipeline Molecules 101

3.8.5 Key Takeaway 101

3.9 Polycythemia Vera 102

3.9.1 Disease Overview 102

3.9.2 Revenues 103

3.9.3 Revenue Analysis by Country 104

3.9.4 Annual Cost of Therapy 108

3.9.5 Treatment Usage Patterns 109

3.9.6 Marketed Products 110

3.9.7 Market Drivers 111

3.9.8 Market Restraints 111

3.10 Polycythemia Vera: Research and Development Pipeline 112

3.10.1 Overview 112

3.10.2 Pipeline by Clinical Phase of Development 113

3.10.3 Trends in Polycythemia Vera Pipeline 116

3.10.4 Promising Pipeline Molecules 118

3.10.5 Key Takeaway 118

4 Acquired Orphan Blood Diseases – Strategic Consolidations 119

4.1 Overview 119

4.1.1 Segmentation by Year 119

4.1.2 Segmentation by Indication 119

4.1.3 Segmentation by Geography 120

4.1.4 Segmentation by Deal Value 120

4.1.5 Segmentation by Deal Type 121

4.2 Major Mergers and Acquisitions 121

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

banner ";